Evidence map›Paper›PMID 21983856›Full record

ArticleNature medicine2011

Epigenetic suppression of GAD65 expression mediates persistent pain.

Zhi Zhang, You-Qing Cai, Fang Zou, Bihua Bie, Zhizhong Z Pan

Registry-linked trialAbstract read
In one paragraph

Article in Nature medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01928849 (Regional Anesthesia and Valproate Sodium for the Prevention of Chronic Post-Amputation Pain), which is not on this map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01928849 phase2completednot on this mapstarted 2013, after this paper: background citation

Regional Anesthesia and Valproate Sodium for the Prevention of Chronic Post-Amputation Pain

TypeinterventionalSponsorDuke UniversityRan2013 to 2017Enrolled128ConditionsPain, Phantom, Pain, NeuropathicArmsValproic Acid, Cherry Syrup
3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 288 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Critical Windows: Exploring the Association Between Perinatal Trauma, Epigenetics, and Chronic Pain.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2024
    Review
  10. Article
  11. Directions for analgesic development.Journal of anesthesia and translational medicine · 2024
    Review
  12. Article
  13. Review
  14. Role of HDAC5 Epigenetics in Chronic Craniofacial Neuropathic Pain.International journal of molecular sciences · 2024
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. The Epigenetics of Neuropathic Pain: A Systematic Update.International journal of molecular sciences · 2023
    Review

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zhi ZhangDepartment of Anesthesiology and Pain Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. zzpan@mdanderson.org
You-Qing Cai
Fang Zou
Bihua Bie
Zhizhong Z Pan
The University of Texas MD Anderson Cancer Center · US

Funding

Synaptic mechanisms for interactions of chronic pain and opioid addictionR01DA027541 · NIDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI PAN, ZHIZHONG Z. · 2009 to 2013
$1.7M
Delta-Opioid Receptor Trafficking and Pain InhibitionR01DA023069 · NIDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI PAN, ZHIZHONG Z. · 2008 to 2012
$1.5M
NIDA NIH HHS DA023069NIDA NIH HHS DA027541NIDA NIH HHS R01 DA023069NIDA NIH HHS R01 DA027541
6 · The paper itself

Abstract

Chronic pain is a common neurological disease involving lasting, multifaceted maladaptations ranging from gene modulation to synaptic dysfunction and emotional disorders. Sustained pathological stimuli in many diseases alter the output activities of certain genes through epigenetic modifications, but it is unclear how epigenetic mechanisms operate in the development of chronic pain. We show here that in the rat brainstem nucleus raphe magnus, which is important for central mechanisms of chronic pain, persistent inflammatory and neuropathic pain epigenetically suppresses Gad2 (encoding glutamic acid decarboxylase 65 (GAD65)) transcription through histone deacetylase (HDAC)-mediated histone hypoacetylation, resulting in impaired γ-aminobutyric acid (GABA) synaptic inhibition. Gad2 knockout mice showed sensitized pain behavior and impaired GABA synaptic function in their brainstem neurons. In wild-type but not Gad2 knockout mice, HDAC inhibitors strongly increased GAD65 activity, restored GABA synaptic function and relieved sensitized pain behavior. These findings suggest GAD65 and HDACs as potential therapeutic targets in an epigenetic approach to the treatment of chronic pain.

Indexed as

Epigenesis, GeneticGene Expression Regulation, EnzymologicAnimalsChronic Diseasegamma-Aminobutyric AcidGlutamate DecarboxylaseHistone Deacetylase InhibitorsHistone DeacetylasesHistonesHumansMaleMiceMice, KnockoutPainPatch-Clamp TechniquesRatsgamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 2Histone Deacetylase InhibitorsHistone DeacetylasesHistones

Identifiers

PMID21983856
PMCPMC3210928
OpenAlexW1990875610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.